Federal Register #DEA-1730P

DEA Notice on Proposed Controlled-Substance Quotas and Chemical Needs

The Drug Enforcement Administration is seeking public input on proposed controlled-substance production quotas and chemical needs assessments. - Government buyer: U.S. Department of Justice, Drug Enforcement Administration (DEA); no specific sub-agency office is identified. - Notice purpose: Request for public comments on proposed aggregate production quotas for Schedule I and II controlled substances and annual needs assessments for ephedrine, pseudoephedrine, and phenylpropanolamine. - Basis for proposed amounts: U.S. medical, scientific, research, and industrial needs; lawful exports; and reserve stocks. - Procurement status: This is a regulatory notice, not a solicitation or government purchase. No OEMs, vendors, products for purchase, quantities, or part numbers are identified.

Description

The Drug Enforcement Administration proposes to establish 2027 aggregate production quotas for Schedule I and II controlled substances and assess annual needs for the List I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. The proposed quantities are intended to meet estimated U.S. medical, scientific, research, and industrial needs, lawful export requirements, and reserve-stock needs. The notice requests comments, which must be submitted or postmarked by December 10, 2026.

View original listing